COGNITIVE FUNCTION (CF) & QUALITY OF LIFE (QOL) IN PATIENTS TREATED WITH PROCARBAZINE, CCNU, & VINCRISTINE (PCV) plus RADIOTHERAPY (RT) VS. RT FOR ANAPLASTIC OLIGODENDROGLIOMA (AO) ON NRG RTOG TRIAL 9402 Conference

Donovan, Laura, Won, Minhee, Cairncross, J Gregory et al. (2021). COGNITIVE FUNCTION (CF) & QUALITY OF LIFE (QOL) IN PATIENTS TREATED WITH PROCARBAZINE, CCNU, & VINCRISTINE (PCV) plus RADIOTHERAPY (RT) VS. RT FOR ANAPLASTIC OLIGODENDROGLIOMA (AO) ON NRG RTOG TRIAL 9402 . NEURO-ONCOLOGY, 23 154-154.

International Collaboration

cited authors

  • Donovan, Laura; Won, Minhee; Cairncross, J Gregory; Iwamoto, Fabio; Buckner, Jan; Fink, Karen; Bahary, Jean-Paul; Hartford, Alan; Souhami, Luis; Nguyen, Timothy; Cescon, Terrence; Mishra, Mark; Barani, Igor; Pu, Anthony; Roa, Wilson; Huang, Jiayi; Polley, Mei; Mehta, Minesh

authors

date/time interval

  • November 18, 2021 -

publication date

  • November 1, 2021

published in

keywords

  • Clinical Neurology
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • Science & Technology

Location

  • MA, Boston

Conference

  • 26th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO)

publisher

  • OXFORD UNIV PRESS INC

start page

  • 154

end page

  • 154

volume

  • 23